John H. Tucker
2021
In 2021, John H. Tucker earned a total compensation of $1.9M as President and Chief Executive Officer at scPharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
Bonus | $128,812 |
---|---|
Non-Equity Incentive Plan | $165,000 |
Option Awards | $1,007,116 |
Salary | $550,000 |
Other | $12,711 |
Total | $1,863,639 |
Tucker received $1M in option awards, accounting for 54% of the total pay in 2021.
Tucker also received $128.8K in bonus, $165K in non-equity incentive plan, $550K in salary and $12.7K in other compensation.
Rankings
In 2021, John H. Tucker's compensation ranked 6,317th out of 12,406 executives tracked by ExecPay. In other words, Tucker earned more than 49.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,317 | 49th |
Manufacturing | 2,687 | 51st |
Chemicals And Allied Products | 1,179 | 50th |
Drugs | 1,049 | 50th |
Pharmaceutical Preparations | 759 | 51st |
Tucker's colleagues
We found one more compensation record of an executive who worked with John H. Tucker at scPharmaceuticals in 2021.
2021
Rachael Nokes
scPharmaceuticals
Senior Vice President of Finance
News
scPharmaceuticals CEO John Tucker's 2022 pay slips 14% to $1.6M
April 27, 2023
scPharmaceuticals CEO John Tucker's 2021 pay rises 7% to $1.9M
April 28, 2022
scPharmaceuticals CEO John Tucker's 2020 pay jumps 40% to $1.7M
April 27, 2021
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019